» Articles » PMID: 33509976

Atrial Fibrillation Prevalence, Awareness and Management in a Nationwide Survey of Adults in China

Overview
Journal Heart
Date 2021 Jan 29
PMID 33509976
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine AF prevalence and gaps in atrial fibrillation (AF) awareness and management in China.

Methods: We conducted a community-based survey of 47 841 adults (age ≥45 years) in seven geographic regions of China between 2014 and 2016. Participants underwent a structured questionnaire, a standard 12-lead ECG, physical examination and blood sampling. AF prevalence, defined by either ECG detection or self-report, was estimated according to sampling weights, non-response and age and sex distribution of the population. We used multivariable logistic regression to estimate associations among sociodemographic, clinical and geographic factors with the AF prevalence, awareness and treatment.

Results: The weighted AF prevalence was 1.8% (95% CI 1.7% to 1.9%), but varied from 0.9% to 2.4% across geographical regions and equates to being present in an estimated 7.9 (95% CI 7.4 to 8.4) million people in China. Among men and women, the AF prevalence increased from 0.8% and 0.6% in the age group 45-54 years to 5.4% and 4.9% in the age group ≥75 years, respectively. Proportions of people who were aware of having AF decreased overall from 65.3% in 45-54 year-olds to 53.9% in ≥75 year-olds and varied between sex (men 58.5%, women 68.8%) and residency status (urban 78.3%, rural 35.3%). Only 6.0% of patients with high-risk AF received anticoagulation therapy.

Conclusions: AF prevalence is higher than previously reported in China, with low awareness and large treatment gaps. Large-scale efforts are urgently needed to reduce AF adverse consequences.

Citing Articles

Intraprocedural activated clotting time and heparin dosage in pulsed field ablation of paroxysmal atrial fibrillation.

Ma C, Xiao X, Chen Q, Li W, Wang Z, Dai S Front Cardiovasc Med. 2025; 12:1501716.

PMID: 40066349 PMC: 11891359. DOI: 10.3389/fcvm.2025.1501716.


Sex-specific trends in the global burden and risk factors of atrial fibrillation and flutter from 1990 to 2021.

Peng X, Wang J, Tang C, He L, Li J, Xia S Sci Rep. 2025; 15(1):8092.

PMID: 40057583 PMC: 11890608. DOI: 10.1038/s41598-025-93338-1.


Association of healthy lifestyle and the incidence of atrial fibrillation in senior adults: a prospective cohort study.

Deng H, Mei Y, Wu C, Gong C, Lai Z, Huang J BMC Geriatr. 2025; 25(1):160.

PMID: 40055644 PMC: 11889794. DOI: 10.1186/s12877-025-05825-9.


The Role of HIF-1α in Atrial Fibrillation: Recent Advances and Therapeutic Potentials.

Zhou F, Zhou J, Wei T, Wu D, Wang R Rev Cardiovasc Med. 2025; 26(2):26787.

PMID: 40026494 PMC: 11868874. DOI: 10.31083/RCM26787.


Atrial fibrillation risk model based on LASSO and SVM algorithms and immune infiltration of key mitochondrial energy metabolism genes.

Yang X, Lan W, Lin C, Zhu C, Ye Z, Chen Z Sci Rep. 2025; 15(1):6681.

PMID: 39994392 PMC: 11850640. DOI: 10.1038/s41598-025-91047-3.


References
1.
Yang X, Li Z, Zhao X, Wang C, Liu L, Wang C . Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China. Stroke. 2015; 47(2):464-70. DOI: 10.1161/STROKEAHA.115.011833. View

2.
Meschia J, Merrill P, Soliman E, Howard V, Barrett K, Zakai N . Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke. 2010; 41(4):581-7. PMC: 2885129. DOI: 10.1161/STROKEAHA.109.573907. View

3.
Soliman E, Howard G, Meschia J, Cushman M, Muntner P, Pullicino P . Self-reported atrial fibrillation and risk of stroke in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke. 2011; 42(10):2950-3. PMC: 3185239. DOI: 10.1161/STROKEAHA.111.621367. View

4.
Svennberg E, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M . Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study. Circulation. 2015; 131(25):2176-84. DOI: 10.1161/CIRCULATIONAHA.114.014343. View

5.
Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R . Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace. 2012; 15(4):486-93. DOI: 10.1093/europace/eus333. View